[
    "ular binding agents identified in screens of chemical libraries such as described below, etc. Agents of particular interest modulate LKK function, e.g. LKK- dependent transcriptional activation. For example, a wide variety of inhibitors of LKK I\u03baB kinase activity may be used to regulate signal transduction involving I\u03baB. Exemplary IKK</p>I\u03baB kinase inhibitors include known classes of serine/threonine kinase (e.g. PKC) \n\ninhibitors such as competitive inhibitors of ATP and substrate binding, antibiotics, LKK- derived peptide inhibitors, etc., see Tables II and III. LKK specificity and activity are readily quantified in high throughput kinase assays using panels of protein kinases (see cited references and Examples).</p>Preferred inhibitors include natural compounds such as staurosporine (Omura S, et al. J Antibiot (Tokyo) 1995 Jul;48(7):535-48), produced by a marine organism, and synthetic compounds such as PD 153035, which also potently inhibits the EGF receptor protein kinase (Fry DW et al. Science 1994 Aug 19;265(5175): 1093-5). Members of the tyrphostin family of synthetic protein kinase inhibitors are also useful; these include compounds which are pure ATP competitors, compounds which are pure substrate competitors, and compounds which are mixed competitors: compete with both ATP and substrate (Levitzki A and Gazit A, Science 1995 Mar 24;267(5205): 1782-8). Additional IKK inhibitors include peptide-based substrate competitors endogenously made by the mammalian cell, e.g. PKI (protein kinase inhibitor, Seasholtz AF et al, Proc Natl Acad Sci USA 1995 Feb 28;92(5): 1734-8 ), or proteins inhibiting cdc kinases (Correa-Bordes J and Nurse P, Cell 1995 Dec 15;83(6): 1001-9). Additional small peptide based substrate competitive kinase inhibitors and allosteric inhibitors (inhibitory mechanisms independent of ATP or substrate competition) are readily generated by established methods (Hvalby O, et al. Proc Natl Acad Sci USA 1994 May 24;91(11):4761-5; Barja P, et al., Cell Immunol 1994 Jan;153(l):28-38; Villar-Palasi C, Biochim Biophys Acta 1994 Dec 30;1224(3):384-8; Liu WZ, et al., Biochemistry 1994 Aug 23;33(33): 10120-6).</p>TABLE II. Selected Small Molecule LKK Kinase Inhibitors</p>HA-100<sup>1</sup> Iso-H7<sup>12</sup> A-3<sup>18</sup></p>Chelerythrine<sup>2</sup> PKC 19-31 HA1004<sup>19</sup>'<sup>20</sup></p>Staurosporine<sup>3</sup>'<sup>4</sup>'<sup>5</sup> \u03c4\u03c4_ -713,3,14 K-252a<sup>16</sup>'<sup>5</sup></p>Calphostin C<sup>6</sup>'<sup>7</sup>'<sup>8</sup>'<sup>9</sup> H-89<sup>15</sup> KT5823<sup>16</sup></p>K-252b<sup>10</sup> KT5720<sup>16</sup> ML-9<sup>21</sup></p>PKC 19-36<sup>11</sup> cAMP-depPKinhib<sup>17</sup> KT5926<sup>22</sup></p>Citations</p>1. Hagiwara, M,. et al. Mol. Pharmacol. 32: 7 (1987) 2. Herbert, J. M., et al. Biochem Biophys Res Com 172: 993 (1990)</p>3. Schachtele, C, et al. Biochem Biophys Res Com 151 : 542 (1988) \n\n4. Tamaoki, T., et al. Biochem Biophys Res Com 135: 397 (1986)</p>5. Tischler, A. S., et al. J. Neuroche",
    " Tween 20 in PBS; 1 hour at room temperature.</p>- Assay Buffer: 100 mM KC1, 10 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, 20 mM HEPES pH 7.4, 0.25 mM EDTA, 1% glycerol, 0.5% NP-40, 50 mM BME, 1 mg/ml BSA, cocktail of protease inhibitors.</p>-[ <sup>32</sup>P]\u03b3-ATP l Ox stock: 2 x 10<sup>\"5</sup> M cold ATP with 100 \u03bcCi [ <sup>32</sup>P]\u03b3-ATP. Place in the 4\u00b0C microfridge during screening.</p>- Protease inhibitor cocktail flOOOX): 10 mg Trypsin Inhibitor (BMB # 109894), 10 mg Aprotinin (BMB # 236624), 25 mg Benzamidine (Sigma # B-6506), 25 mg Leupeptin (BMB # 1017128), 10 mg APMSF (BMB # 917575), and 2mM NaVo<sub>3</sub> (Sigma # S-6508) in</p>10 ml of PBS.</p>B . Preparation of assay plates:</p>- Coat with 120 \u03bcl of stock N Avidin per well overnight at 4\u00b0C.</p>- Wash 2 times with 200 \u03bcl PBS. - Block with 150 \u03bcl of blocking buffer.</p>- Wash 2 times with 200 \u03bcl PBS.</p>C. Assay:</p>- Add 40 \u03bcl assay buffer/well.</p>- Add 40 \u03bcl biotinylated substrate (2-200 pmoles/40 ul in assay buffer) - Add 40 \u03bcl kinase (0.1-10 pmoles/40 ul in assay buffer)</p>- Add 10 \u03bcl compound or extract.</p>- Add 10 \u03bcl [<sup>32</sup>P]\u03b3-ATP lOx stock.</p>- Shake at 25 \u00b0C for 15 minutes.</p>- Incubate additional 45 minutes at 25 \u00b0C. - Stop the reaction by washing 4 times with 200 \u03bcl PBS.</p>- Add 150 \u03bcl scintillation cocktail. \n\n - Count in Topcount.</p>D. Controls for all assays (located on each plate): a. Non-specific binding b. cold ATP at 80% inhibition.</p>2. Protocol for high throughput LKK-\u03b1-NLK binding assay.</p>A. Reagents:</p>- Neutralite Avidin: 20 \u03bcg/ml in PBS.</p>- Blocking buffer: 5% BSA, 0.5% Tween 20 in PBS; 1 hour at room temperature.</p>- Assay Buffer: 100 mM KC1, 20 mM HEPES pH 7.6, 1 mM MgCl<sub>2</sub>, 1% glycerol, 0.5%) NP-40, 50 mM \u03b2-mercaptoethanol, 1 mg/ml BSA, cocktail of protease inhibitors.</p>- -P TKK-\u03b1 polypeptide I Qx stock: 10<sup>\"8</sup> - 10<sup>\"6</sup> M \"cold\" LKK-\u03b1 supplemented with 200,000-250,000 cpm of labeled LKK-\u03b1 (Beckman counter). Place in the 4\u00b0C microfridge during screening.</p>- Protease inhibitor cocktail (1000X : 10 mg Trypsin Inhibitor (BMB # 109894), 10 mg Aprotinin (BMB # 236624), 25 mg Benzamidine (Sigma # B-6506), 25 mg Leupeptin</p>(BMB # 1017128), 10 mg APMSF (BMB # 917575), and 2mM NaVO<sub>3</sub> (Sigma # S-6508) in 10 ml of PBS.</p>-NLK: 10<sup>\"7</sup> - 10<sup>\"5</sup>M biotinylated NLK in PBS.</p>B. Preparation of assay plates: - Coat with 120 \u03bcl of stock N-Avidin per well overnight at 4\u00b0C.</p>- Wash 2 times with 200 \u03bcl PBS.</p>- Block with 150 \u03bcl of blocking buffer.</p>- Wash 2 times with 200 \u03bcl PBS.</p>C. Assay: - Add 40 \u03bcl assay buffer/well.</p>- Add 10 \u03bcl compound or extract.</p>- Add 10 \u03bcl <sup>33</sup>P-LKK-\u03b1 (20-25,000 cpm/0.1-10 pmoles/well =10<sup>\"9</sup>- 10<sup>\"7</sup> M final cone).</p>- Shake at 25\u00b0C for 15 minutes.</p>- Incubate additional 45 minutes at 25\u00b0C. - Add 40 \u03bcM biotinylated NLK (0.1-10 pmoles/40 ul in assay buffer)</p>- Incubate 1 hour at room temperature. \n\n - Stop the reaction by w"
]